Scottie Resources Corp. (TSXV: SCOT)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
NuScale Power (SMR), a developer of small modular reactors (SMRs), holds unique technological advantages and a first-mover edge in the SMR sector. The approval from the U.S. Nuclear Regulatory Commission (NRC) has established a significant competitive moat, while its substantial project pipeline and ample cash reserves provide support for future development. However, the company currently faces severe challenges, including persistently widening losses, a sharp decline in revenue, class-action lawsuits, and intensifying market competition. NuScale Power’s stock price has remained sluggish recently, currently trading at around $11, far below its all-time high of $53.43 set in October of last year.
NuScale’s core moat lies in the NRC’s design approval, which places it months or even years ahead of competitors seeking the same milestone. This advantage is particularly critical at a time when utilities and data centers are urgently seeking reliable sources of electricity.
The company’s project pipeline is considerable. NuScale is working with commercial partner ENTRA1 Energy to assist the Tennessee Valley Authority (TVA) in deploying up to 6 gigawatts of SMR capacity. In addition, NuScale is collaborating with RoPower Nuclear to advance a project in Romania. Although the project is being executed in phases, successful completion would represent a major positive for NuScale investors. These two projects are expected to generate substantial revenue for the company by the early 2030s.
On the financial front, NuScale holds approximately $900 million in cash reserves and short-term investments. This capital provides the company with ample operating runway, allowing it to continue its commercialization efforts without the risk of dilution or running out of funds.
However, the risks facing NuScale are equally real. In 2025, the company generated only $31.5 million in revenue, while its net loss reached $355.8 million, a 160% surge from the previous year. In the first quarter of 2026, revenue plummeted to nearly zero. Wall Street analysts have reacted negatively, with some firms lowering their price targets or ratings. Even the more optimistic analysts acknowledge that material revenue may still be at least several years away.
Class-action lawsuits also pose a major challenge for the company. The litigation alleges that NuScale executives misled investors regarding ENTRA1’s capabilities. This could not only result in financial losses, but reputational damage may prove even harder to repair.
Competitive pressures are equally significant. Companies like Oklo (OKLO) represent a real threat, especially if NuScale fails to successfully deliver its pipeline projects. This week, Oklo announced a partnership with Standard Nuclear to strengthen its nuclear supply chain and further align with federal power goals in the age of artificial intelligence.
NuScale’s stock is highly volatile, with a beta exceeding 2, meaning its fluctuations are more than twice those of the broader market. Year-to-date, the stock has fallen over 26%, trading well below its 52-week high of $57.
Bullish arguments hold that SMRs will reshape the nuclear energy market, meeting the growing energy demands of cloud services, artificial intelligence, and industrial automation. Bearish views contend that the company will face difficulties in growing its business amid intense competition and macroeconomic headwinds.
From a financial forecast perspective, analysts project NuScale’s revenue will grow from $31.5 million in 2025 to $310.7 million in 2028, primarily driven by front-end engineering and design studies, licensing transactions, and consulting work. However, based on a market capitalization of $3.4 billion, the stock is already trading at 11 times expected 2028 sales, and the company remains unprofitable in the near to medium term. Fluor (FLR), which previously held more than half of NuScale’s shares, has liquidated its remaining stake, and company insiders have continued to be net sellers.
The stock’s high volatility and the lengthy commercialization cycle require investors to have considerable risk tolerance and long-term investment patience. For long-term investors who are optimistic about the nuclear energy renaissance and can withstand high volatility, prices below $15 may present an opportunity; however, for risk-averse investors, waiting for clearer signs of commercialization might be the more prudent choice.
